Pelvic exenteration for advanced pelvic malignancy

Seminars in Surgical Oncology

Volumn 17, Issue 3, 1999, Pages 152-160

  Crowe, Philip J ^a,d   Temple, Walley J ^a   Lopez, Marvin J ^b   Ketcham, Alfred S ^c  

^a TOM BAKER CANCER CENTRE   (Canada)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Brachytherapy; Cervical neoplasms; Colorectal neoplasms; Combined modality therapy; Emission computed tomography; Lymphatic metastasis; Magnetic resonance imaging; Male genital neoplasms; Morbidity; Mortality; Neoplasm metastasis; Palliative care; Patient selection; Pelvic exenteration; Pelvic neoplasms; Postoperative care; Postoperative complications; Preoperative care; Quality of life; Radioimmunodetection; Radiotherapy; Rectal neoplasms; Surgical flaps; Survival rate; Vaginal neoplasms; Vulvar neoplasms; X ray computed tomography

Indexed keywords

BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; COMORBIDITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATIENT SELECTION; PELVIS CANCER; PELVIS EXENTERATION; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE DISEASE; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; PELVIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0032834449     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199910/11)17:3<152::AID-SSU3>3.0.CO;2-J     Document Type: Review

References (77)

1. Brunschwig A: Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into colon above the colostomy. Cancer 1948;1:177-183.
2. Bricker EM: Bladder substitution after pelvic evisceration. Surg Clin North Am 1950; 30:1511-1521.
3. Avradopoulos KA, Vezeridis MP, Wanebo HJ: Pelvic exenteration for recurrent rectal cancer [Review]. Adv Surg 1996;29:215-233.
4. Lopez MJ, Standiford SB, Skibba JL: Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center [published erratum appears in Arch Surg 1994;129:777]. Arch Surg 1994;129:390-396.
5. Goldberg JM, Piver MS, Hempling RE, et al: Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality. Ann Surg Oncol 1998;5:399-406.
6. Hafner GH, Herrera L, Petrelli NJ: Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 1992;215:63-67.
7. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL: Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 1989;35:93-98.
8. Anthopoulos AP, Manetta A, Larson JE, et al: Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience. Gynecol Oncol 1989;35:219-223.
9. Plukker JT, Aalders JG, Mensink HJ, Oldhoff J: Total pelvic exenteration: a justified procedure. Br J Surg 1993;80:1615-1617.
10. Lopez MJ, Kraybill WG, Downey RS, et al: Exenterative surgery for locally advanced rectosigmoid cancers. Is it worthwhile? [published erratum appears in Surgery 1988;103:388]. Surgery 1987;102:644-651.
11. Heald RJ: Total mesorectal excision. The new European gold standard [editorial]. Giornale Chir 1998;19:253-255.
12. Carlsen E, Schlichting E, Guldvog I, et al: Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-529.
13. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial [published erratum appears in N Engl J Med 1997;336:1539]. N Engl.J Med 1997;336:980-987.
14. Brodsky JT, Sloane BB, Khanna OP: Total pelvic exenteration with preservation of fecal continence. J Surg Oncol 1993;53:261-264.
15. Goluboff ET, McKiernan JM, Todd G, et al: Reconstruction of urinary and gastrointestinal tracts in total pelvic exenteration: experience at Columbia-Presbyterian Medical Center. Urology 1994; 44:666-670.
16. Shepherd JH, Crawford RA, Christmas TJ, Hendry WF: Total pelvic reconstruction after exenteration for recurrent cervical cancer. Br J Urol 1997;80 Suppl 1:79-81.
17. Finlayson CA, Eisenberg BL: Palliative pelvic exenteration: patient selection and results [Review]. Oncology 1996:10:479-486, 490,493.
18. McCullough WM, Nahhas WA: Palliative pelvic exenteration - futility revisited. Gynecol Oncol 1987;27:97-103.
19. Lawhead RA Jr, Clark DG, Smith DH, et al: Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981). Gynecol Oncol 1989;33:279-282.
20. Miller B, Morris M, Rutledge F, et al: Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol 1993;50:94-99.
21. Woodhouse CR, Plail RO, Schlesinger PE, et al: Exenteration as palliation for patients with advanced pelvic malignancy. Br J Urol 1995;76:315-320.
22. Brophy PF, Hoffman JP, Eisenberg BL: The role of palliative pelvic exenteration [published erratum appears in Am J Surg 1994; 168:216]. Am J Surg 1994; 167:386-390.
23. Baigrie RJ, Berry AR: Management of advanced rectal cancer [Review]. Br J Surg 1994;81:343-352.
24. Tjandra JJ: Surgical management of the locally advanced pelvic malignancy - the colorectal surgeon's view [Review]. Ann Acad Med Singapore 1995;24:271-276.
25. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA: Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-943.
26. Zincke H: Radical prostatectomy and exenterative procedures for local failure after radiotherapy with curative intent: comparison of outcomes. J Urol 1992;147(3 Pt 2):894-899.
27. Reid GC, Morley GW, Schmidt RW, Hopkins MP: The role of pelvic exenteration for sarcomatous malignancies. Obstet Gynecol 1989;74:80-84.
28. Leake JF: Tumors of low malignant potential [Review]. Curr Opin Obstet Gynecol 1992;4:81-85.
29. Hida J, Yasutomi M, Maruyama T, et al: Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum 1998;41:165-168.
30. Tarraza HM, Ellerkmann RM: Pelvic radical surgery [Review]. Surg Oncol Clin North Am 1998;7:399-416.
31. Hockel M, Sclenger K, Hamm H, et al: Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 1996; 77:1918-1933.
32. Wanebo HJ, Koness RJ, Vezeridis MP, et al: Pelvic resection of recurrent rectal cancer. Ann Surg 1994;220:586-597.
33. Temple WJ, Ketcham AS: Sacral resection for control of pelvic tumors. Am J Surg 1992;163:370-374.
34. Matthews CM, Morris M, Burke TW, et al: Pelvic exenteration in the elderly patient. Obstet Gynecol 1992;79(5 Pt 1):773-777.
35. Lichtinger M, Averette H, Penalver M, Sevin BU: Major surgical procedures for gynecologic malignancy in elderly women. South Med J 1986;79:1506-1510.
36. Manetta A, Podczaski ES, Larson JE, et al: Scalene lymph node biopsy in the preoperative evaluation of patients with recurrent cervical cancer. Gynecol Oncol 1989; 33:332-334.
37. Popovich MJ, Hricak H, Sugimura K, Stern JL: The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 1993;160:525-531.
38. Yeung RS, Moffat FL, Falk RE: Pelvic exenteration for recurrent colorectal carcinoma: a review [Review]. Cancer Invest 1994; 12:176-188.
39. Smith FW, Heys SD, Evans NT, et al; Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy. Nucl Med Commun 1992;13:193-195.
40. Engenhart R, Kimmig BN, Strauss LG, et al: Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 1992;168:203-212.
41. Zeisler H, Joura EA, Moeschl P, et al: Preoperative evaluation of tumor extension in patients with recurrent cervical cancer. Acta Obstet Gynecol Scand 1997; 76:474-477.
42. Plante M, Roy M: Operative laparoscopy prior to a pelvic exenteration in patients with recurrent cervical cancer. Gynecol Oncol 1998;69:94-99.
43. Mohiuddin M, Marks GM, Lingareddy V, Marks J: Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997;39:643-649.
44. Schultheiss TE, Kun LE, Ang KK, Stephens LC: Radiation response of the central nervous system [Review][published erratum appears in Int J Radiat Oncol Biol Phys 1995;32:1269]. Int J Radiat Oncol Biol Phys 1993;31:1093-1112.
45. Beitler JJ, Anderson PS, Wadler S, et al: Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival? Int J Radiat Oncol Biol Phys 1997;38:143-148.
46. Tepper JE, Cohen AM, Wood WC, et al: Intraoperative electron beam radiotherapy in the treatment of unresectable rectal cancer. Arch Surg 1986;121:421-423.
47. Nag S, Martinez-Monge R, Mills J, et al: Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol 1996;33:526-533.
48. Huber FT, Stepan R, Zimmermann F, et al: Locally advanced rectal cancer: resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy. Dis Colon Rectum 1996;39:774-779.
49. Spratt JS, Lopez MJ: Pelvic exenteration and ilioinguinal lymph node dissection. Surg Oncol Clin North Am 1994;3:217-237.
50. Lopez MJ: Pelvic exenteration. In Cady B, Daly J (eds): "Atlas of surgical oncology." Chicago: Mosby-Year Book; 1993. p. 555.
51. Rodriguez-Bigas MA, Petrelli NJ, Lopez MJ, Petros JG: Modified pelvic exenteration. Surg Oncol Clin North Am 1994;3:239-246.
52. Wanebo HJ, Marcove RC: Abdominal sacral resection of locally advanced recurrent rectal cancer. Ann Surg 1981;194:458-471.
53. Sugarbaker PH: Partial sacrectomy for en bloc excision of rectal cancer with posterior fixation. Dis Colon Rectum 1982;25:708-711.
54. Skinner DG, Sherrod A: Total pelvic exenteration with simultaneous bowel and urinary reconstruction. J Urol 1990;144:1433-1439.
55. Magrina JF: Types of pelvic exenterations: a reappraisal. Gynecol Oncol 1990;37:363-366.
56. Bertsch DJ, Burak WE Jr, Young DC, et al: Radioimmunoguided Surgery system improves survival for patients with recurrent colorectal cancer [Review]. Surgery 1995;118:634-639.
57. Percivale P, Bertoglio S, Meszaros P, et al: Radioimmunoguided surgery with different iodine-125 radiolabelled monoclonal antibodies in recurrent colorectal cancer. Semin Surg Oncol 1998;15:231-234.
58. Buchsbaum HJ, Christopherson W, Lifshitz S, Bernstein S: Vicryl mesh in pelvic floor reconstruction. Arch Surg 1985;120:1389-1391.
59. Hoffman MS, Roberts WS, LaPolla JP, et al: Use of Vicryl mesh in the reconstruction of the pelvic floor following exenteration. Gynecol Oncol 1989;35:170-171.
60. Magrina JF, Stanhope CR, Weaver AL: Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol 1997;64:130-135.
61. Shirouzu K, Isomoto H, Kakegawa T: Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg 1996;83:32-35.
62. Rodriquez Cuevas H, Torres A, de la Garcia M, et al: Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases [Review]. J Surg Oncol 1988;38:121-125.
63. Roberts WS, Cavanagh D, Bryson SC, et al: Major morbidity after pelvic exenteration: a seven-year experience. Obstet Gynecol 1987;69:617-621.
64. Bladou F, Houvenaeghel G, Delpero JR, Guerinel G: Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies. J Surg Oncol 1995; 58:91-96.
65. Jakowatz JG, Porudominsky D, Riihimaki DU, et al: Complications of pelvic exenteration. Arch Surg 1985;120:1261-1265.
66. Hafner GH, Herrera L, Petrelli NJ: Patterns of recurrence after pelvic exenteration for colorectal adenocarcinoma. Arch Surg 1991;126:1510-1513.
67. Kim HK, Jessup JM, Beard CJ, et al: Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997;38:777-783.
68. Meterissian SH, Skibber JM, Giacco GG, et al: Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival [Review]. Surgery 1997;121:479-487.
69. Crowe PJ, Yang JL, Berney CR, et al: Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 1999. In press.
70. Stanhope CR, Symmonds RE: Palliative exenteration - what, when, and why? Am J Obstet Gynecol 1985;152:12-16.
71. Yeung RS, Moffat FL, Falk RE: Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer 1993;72:1853-1858.
72. Carlson JW, Soisson AP, Fowler JM, et al: Rectus abdominis myocutaneous flap for primary vaginal reconstruction. Gynecol Oncol 1993;51:323-329.
73. Eisenkop SM, Nalick RH, Teng NN: Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991;78(5 Pt 1):879-885.
74. Esrig D, Freeman JA, Stein JP, et al: New technique of vaginal reconstruction following anterior exenteration. Urology 1997; 49:768-771.
75. Hawighorst-Knapstein S, Schonefussrs G, Hoffmann SO, Knapstein PG: Pelvic exenteration: effects of surgery on quality of life and body image - a prospective longitudinal study. Gynecol Oncol 1997;66:495-500.
76. Ratliff CR, Gershenson DM, Morris M, et al: Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer 1996; 78:2229-2235.
77. Smith HO, Genesen MC, Runowicz CD, Goldberg GL: The rectus abdominis myocutaneous flap: modifications, complications, and sexual function. Cancer 1998;83:510-520.